Amendment to the 2025/26 Invitation to Tender – 01 December 2025

Pharmac has amended the 2025/26 Invitation to Tender with the following updates:

• Added: thiamine hydrochloride inj 100 mg per ml, 1 ml

• Amended: 

  
  

  • bupivacaine hydrochloride with adrenaline inj 0.25% with 1:400,000 of adrenaline, 20 ml non-sterile pack → bupivacaine hydrochloride with adrenaline inj 0.25% with 1:400,000 of adrenaline, 20 ml

  • bupivacaine hydrochloride with adrenaline inj 0.5% with 1:200,000 of adrenaline, 20 ml non-sterile pack → bupivacaine hydrochloride with adrenaline inj 0.5% with 1:200,000 of adrenaline, 20 ml

  • colecalciferol oral liq 188 mcg per ml (7,500 iu per ml) → colecalciferol oral liq 10 mcg per drop (400 iu per drop)

  • thiamine hydrochloride inj 100 mg per ml, 2 ml: Added the Schedule Two comment “Pharmac reserves the right to award a single tender for the whole thiamine inj 100 mg per ml market, or two separate tenders for the 1 ml and 2 ml presentations”.

These changes have been reflected in the In-Tend e-portal, and in the following website attachments:

• 2025-11-03 Invitation to Tender (includes Schedule 2)

• 2025/26 Invitation to Tender Notification

• Schedule 2 (Excel spreadsheet)

• Hospital usage data 2025/26

Ngā mihi,

Jade Matthews-Wanden | Tender Analyst

Te Pātaka Whaioranga | Pharmac | PO Box 10 254 | Level 9, 40 Mercer Street, Wellington | P: 0800 660 050 | www.pharmac.govt.nz